ClinicalTrials.gg
Not yet recruitingNCT07845734Updated Oct 5, 2026

Music-Accompanied Nature Imagery on Blood Pressure and Pain in Intensive Care Unit Patients

An interventional study of Viewing Nature Imagery Accompanied by Music in ICU Patients, sponsored by Cumhuriyet University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Cumhuriyet University · Not applicable, Interventional, and Health services research

How we know

Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to evaluate the effect of viewing nature imagery accompanied by music on blood pressure and pain in intensive care unit patients compared with standard care.

The questions to be answered within the scope of the research are:

Does viewing nature imagery accompanied by music affect blood pressure in intensive care unit patients compared with standard care? Does viewing nature imagery accompanied by music affect pain levels in intensive care unit patients compared with standard care?

Participants will:

The patients will be divided into two groups: an intervention group and a control group.

The intervention group will Patients in the intervention group will be exposed to nature imagery accompanied by music once daily for 30 minutes over five consecutive days. Blood pressure and pain levels will be assessed before, during, and after each session.

The control group will continue with routine intensive care unit follow-up treatments.

Read the detailed description

Patients in the intervention group will be administered a questionnaire Demographic Information Form and Visual Analog Scale (VAS). Blood pressure will be measured using a bedside patient monitor. Patients will be shown nature scenery accompanied by music once a day for five days; the scenery will be displayed on a tablet, and the music will be played via headphones. The intervention will consist of nature-themed visuals-such as forests, seas, lakes, and waterfalls-paired with relaxing, instrumental, wordless music played at a tempo of 60-80 beats per minute (BPM). Vivaldi's classical compositions will be selected for the music. This procedure will be administered by an intensive care nurse. Measurements will be taken prior to the intervention, at the 15th minute of the intervention, at the end of the intervention (30th minute), and 15 minutes after the intervention has concluded. Measurements will be taken over a period of 5 days.

Control Group Patients in the control group will also be administered the Demographic Information Form and VAS. Blood pressure measurements and pain assessments for patients in the control group will be performed concurrently with those for patients in the intervention group. Patients in the control group will not undergo any intervention during the study period, and their routine intensive care treatment and care will continue. Blood pressure and pain levels in the patients in the control group will be evaluated over a period of five days.

02

Conditions studied

  • ICU Patients
03

In context

Lead sponsor

Cumhuriyet University is the lead sponsor of 135 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older,
  • Having a Glasgow Coma Scale (GCS) score of ≥14,
  • Being hemodynamically stable,
  • Having adequate hearing and visual functions,
  • Being able to verbally express pain,
  • Having a stay in the intensive care unit of at least 5 days,
  • Having no speech or communication problems.

Exclusion criteria

Exclusion Criteria:

  • Being under the age of 18,
  • Having a diagnosis of delirium,
  • Presence of hemodynamic instability,
  • Receiving high-dose vasopressor therapy,
  • Being under sedation,
  • Having severe hearing or visual impairment,
  • Declining to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Intervention Group: Viewing Nature Imagery Accompanied by Music

    Patients in the intervention group will complete a Demographic Information Form and the Visual Analog Scale (VAS). Blood pressure will be measured using a bedside patient monitor. Patients will view nature scenery (e.g., forests, seas, lakes, and waterfalls) displayed on a tablet while listening to relaxing, wordless instrumental music through headphones. Vivaldi's classical compositions with a tempo of 60-80 beats per minute will be used. The intervention will be administered by an intensive care nurse once daily for 30 minutes over five consecutive days. Blood pressure and pain levels will be assessed before the intervention, at the 15th minute, immediately after the intervention, and 15 minutes after completion on each of the five days.

    Other: Viewing Nature Imagery Accompanied by Music

  • No intervention
    Control Group: Usual care

    atients in the control group will complete the Demographic Information Form and VAS. Blood pressure and pain levels will be assessed at the same time points as in the intervention group over five consecutive days. No additional intervention will be provided, and routine intensive care treatment and nursing care will continue.

Interventions

  • OtherViewing Nature Imagery Accompanied by Music

    As part of the non-invasive intervention to be administered to the intervention group, patients will be shown nature and landscape visuals accompanied by music once daily for 30 minutes over a total of five consecutive days. The intervention will consist of nature-themed visuals-such as forests, seas, lakes, and waterfalls-paired with relaxing, instrumental, and wordless music played at a tempo of 60-80 beats per minute (BPM). Classical music compositions by Vivaldi will be selected for the musical component.

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale

    The study by Hayes and Patterson (1921) is considered a foundational source for the widespread adoption of the VAS in modern clinical pain measurement. Its clinical use in pain assessment was subsequently popularized, particularly by Huskisson (1974). It represents pain on a scale ranging from 0 (no pain) to 10 (severe pain). The patient indicates the intensity of the pain they are experiencing by marking a point on the line. The measurement can be scored on a 0-10 scale or a 0-100 mm scale.

    Time frame: VAS measurements: Before the nature imagery and music viewing session (baseline value) At the 15th minute of the session At the end of the session (30th minute) 15 minutes after the nature imagery and music viewing session

  2. Blood Pressure

    Systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) will be evaluated as primary physiological variables in the study. The values will be measured using a bedside monitor.

    Time frame: Before the nature imagery and music viewing session (baseline value) • At the 15th minute of the session • At the end of the session (30th minute) • 15 minutes after the nature imagery and music viewing session

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Feb 2027, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Sep 29, 2026
StartEst.
Sep 30, 2026
Primary completionEst.
Feb 28, 2027
CompletionEst.
Mar 1, 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 2 updates
  1. Oct 5, 2026
    Minor edits only
    + 2 other changes: verification date and criteria formatting
  2. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07845734
Responsible party
Esra Baser Akin (Assistant Professor, Cumhuriyet University) — Principal investigator
First posted
Sep 29, 2026
Start date
Sep 30, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Esra Başer Akın, PhD
Contact
esra_baser568@hotmail.com
+90 538 478 06 60

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion